Mol. Cells 2015; 38(5): 409-415
Published online May 7, 2015
https://doi.org/10.14348/molcells.2015.2266
© The Korean Society for Molecular and Cellular Biology
Correspondence to : *Correspondence: kchoi@postech.ac.kr
Low-barrier hydrogen bonds (LBHBs) have been proposed to have important influences on the enormous reaction rate increases achieved by many enzymes. Δ5-3-ketosteroid isomerase (KSI) catalyzes the allylic isomerization of Δ5-3-ketosteroid to its conjugated Δ4-isomers at a rate that approaches the diffusion limit. Tyr14, a catalytic residue of KSI, has been hypothesized to form an LBHB with the oxyanion of a dienolate steroid intermediate generated during the catalysis. The unusual chemical shift of a proton at 16.8 ppm in the nuclear magnetic resonance spectrum has been attributed to an LBHB between Tyr14 Oη and C3-O of equilenin, an intermediate analogue, in the active site of D38N KSI. This shift in the spectrum was not observed in Y30F/Y55F/D38N and Y30F/Y55F/Y115F/D38N mutant KSIs when each mutant was complexed with equilenin, suggesting that Tyr14 could not form LBHB with the intermediate analogue in these mutant KSIs. The crystal structure of Y30F/Y55F/Y115F/D38N-equilenin complex revealed that the distance between Tyr14 Oη and C3-O of the bound steroid was within a direct hydrogen bond. The conversion of LBHB to an ordinary hydrogen bond in the mutant KSI reduced the binding affinity for the steroid inhibitors by a factor of 8.1?11. In addition, the absence of LBHB reduced the catalytic activity by only a factor of 1.7?2. These results suggest that the amount of stabilization energy of the reaction intermediate provided by LBHB is small compared with that provided by an ordinary hydrogen bond in KSI.
Keywords enzyme catalysis, ketosteroid isomerase, low-barrier hydrogen bond, Tyr14
One of the fundamental questions in enzyme catalysis is how an enzyme can stabilize a reaction intermediate and transition state during enzymatic reaction to accelerate the enzyme-catalyzed reaction rate over the non-enzymatic one. The low-barrier hydrogen bond (LBHB) has been invoked to explain a large amount of the energy that is required to stabilize the intermediate in many enzyme reactions (Gerlt and Gassman, 1993). An LBHB has been hypothesized to occur when the distance between the two heteroatoms is less than the sum of their van der Waals radii and the p
Δ5-3-ketosteroid isomerase (KSI) catalyzes the allylic rearrangement of the 5,6 double bond of Δ5-3-ketosteroids to the 4,5 position, and accelerates the reaction by a factor of 1011 compared to the nonenzymatic reaction by an intramolecular proton transfer (Fig. 1) (Pollack, 2004). Two bacterial KSIs, one from
In this study, we measured the energetic difference between LBHB and the ordinary hydrogen bond in the active site of
5-androstene-3,17-dione (5-AND), androstenolone, equilenin and estrone were purchased from Steraloids Inc. (USA). 15N-Labeled NH4Cl was purchased from Cambridge Isotope Laboratories Inc. (USA). A Superose 12 gel filtration column was purchased from Amersham Bioscience (USA). All chemicals for the buffer solution were purchased from Sigma (USA). All enzymes for DNA manipulation were purchased from Promega (USA). Oligonucleotides were obtained from Genotech Inc. (Korea).
Site-directed mutagenesis of Y115F, Y115F/D38N, Y30F/Y55F/Y115F, Y30F/Y55F/D38N and Y30F/Y55F/Y115F/D38N was conducted as described previously (Kim et al., 2000). All mutations were confirmed by sequencing the entire gene of the mutant KSI. Mutant KSIs were overexpressed in
NMR was performed as described previously (Jang et al., 2006). The NMR sample was adjusted to contain 15 mg/ml KSI in 40 mM potassium phosphate buffer at pH 7.0 containing 1 mM EDTA and 10% DMSO-d6 (dimethyl sulfoxide-d6) (v/v). NMR spectra were collected on a spectrometer (Bruker, Avance DRX500) equipped with a triple resonance, pulse field gradient probe with actively-shielded z-axis gradients, and a gradient amplifier unit. A jump-and-return pulse sequence (Plateau and Gueron, 1982) was used to suppress the water signal. The observed 1H chemical shifts were determined relative to that of sodium 2,2-dimethyl-2-silapentane-5-sulfonate as an internal standard. All experiments were conducted at 270 K with 1,000 scans acquired for each spectrum; the relaxation delay was 2 s. The spectral width of 20,000 Hz was used in 16,384 points. Line-broadening of 10 Hz was used when processing the data on a workstation (Silicon Graphics, IndyPC) using a software program XWIN-NMR v. 1.2.
The affinity of KSI for equilenin, androstenolone, or estrone was assessed by measuring the extent of quenching of intrinsic tryptophan fluorescence of KSI upon the binding of the respective steroid. The fluorescence intensities of KSI were measured with excitation at 295 nm and emission at 315 nm after adding successively various amounts of the steroid dissolved in DMSO to the solution of KSI. After correcting the data with appropriate dilution factors, dissociation constants were determined by fitting the data to the following equation:
Enzymatic reactions were initiated by adding KSI to 3 ml of a solution containing 34 mM potassium phosphate, pH 7.0, 2.5 mM EDTA, 3.3% methanol, and the respective amount of a steroid substrate, 5-AND. The final concentration of methanol in the reaction mixture was 3.3% by volume. All the assays were performed at 298 K. Kinetic parameters such as
Crystallization of Y30F/Y55F/Y115F/D38N KSI complexed with equilenin was conducted using a hanging drop vapor diffusion method as described previously (Cha et al., 2014; Cho et al., 1999). After 20 mg/ml of the mutant KSI was prepared in a buffer containing 40 mM potassium phosphate, pH 7.0, 1 mM EDTA, and 20 mM β-mercaptoethanol, the 70 μl of this solution was mixed with 2 μl of 10 mM equilenin in dimethyl sulfoxide. The optimized crystallization for the mutant KSI was 0.1 M sodium acetate, pH 4.5, 0.6 M ammonium acetate, and 30% PEG 4000. All diffraction data were collected on beamline 5C at Po-hang Accelerator Laboratory (PAL), Korea. The diffraction images were integrated and scaled using the HKL-2000 software package (Otwinowski and Minor, 1997). The structure of Y30F/Y55F/Y115F/D38N complexed with equilenin was determined by the molecular replacement method using as a search model the coordinates of wild-type KSI that had been determined previously (Kim et al., 1997a). Model building was performed using Coot (Emsley et al., 2010) and refinement was performed using Phenix.refine (Afonine et al., 2012). The atomic coordinate of Y30F/Y55F/Y115F/D38N complexed with equilenin was deposited at the Protein Data Bank (PDB code 5AI1).
The Y30F/Y55F/Y115F/D38N mutant KSI that contains no tyrosine residue other than Tyr14 was prepared to investigate the role of Tyr14 in the formation of LBHB without any interference from the other three tyrosines (Tyr30, Tyr55, Tyr115) in
The
The
The binding mode of equilenin in the active site of Y30F/Y55F/Y115F/D38N was investigated using X-ray crystallography. The crystals of Y30F/Y55F/Y115F/D38N-equilenin complex were found to belong to the C2221 space group with unit cell dimensions of a = 35.2 ?, b = 95.8 ? and c = 73.5 ?. The final structure of Y30F/Y55F/Y115F/D38N-equilenin complex was determined at 2.1-? resolution. The crystallographic statistics for the final structure are shown in Supplementary Table 1. The crystal structure of the mutant revealed that the benzyl side chains of the substituted phenylalanines were located at the positions similar to those of the corresponding tyrosine residues in D38N but without the hydroxyl groups (Fig. 4). The hydrogen bond geometry between equilenin and catalytic residues in Y30F/Y55F/Y115F/D38N was very similar to that in D38N. The bound steroid was located in the active site of the mutant with the steroid A-ring approaching Tyr14 and Asp99 (Fig. 4; Supplementary Fig. 1). Three catalytic residues, Tyr14, Asp38 and Asp99, which are critical for the catalytic activity of KSI, were found to be located at positions similar to those in D38N. Tyr14 Oη was involved in a hydrogen bond with C3-O of equilenin with a distance of 2.80 ? in the active site of Y30F/Y55F/Y115F/D38N complexed with the steroid.
Using KSI as a model system, we investigated the nature and origin of stabilization of the reaction intermediate or the transition-state to explain the enormous rate enhancement of the enzyme-catalyzed reaction over the non-enzymatic reaction. Especially, we investigated the proposition that LBHB can provide an additional energetic contribution to enzyme catalysis compared with the ordinary hydrogen bond. In
Tyr14 Oη forms a hydrogen bond with Tyr55 Oη that is in turn hydrogen-bonded to Tyr30 Oη in the active site of
The 1H NMR spectrum and crystal structure of the Y30F/Y55F/Y115F/D38N KSI complexed with equilenin revealed that LBHB between Tyr14 Oη and C3-O of the steroid in D38N was replaced by an ordinary hydrogen bond. The affinities of the Y30F/Y55F/Y115F/D38N KSI for steroid inhibitors (androstenolone, estrone, equilenin), were lower by factors of 9.1?11 than those of the D38N KSI; this change corresponds to a decrease of only 1.3?1.4
The proton transfer by KSI from the C4 proton of 5-AND with p
In conclusion, we have shown that the conversion of LBHB to an ordinary hydrogen bond resulted in only marginal decrease of the catalytic activity and the binding affinity for the intermediate analogue in
. Effects of the tyrosine-to-phenylalanine substitutions in
KSI | Highly deshielded1H resonance (ppm)c | |
---|---|---|
D38N | (3.1 ± 0.6) × 10?2 | 16.8 |
Y30F/D38N | (0.7 ± 0.1) × 10?2 | 17.6 |
Y55F/D38N | (0.8 ± 0.2) × 10?2 | 17.9 |
Y115F/D38N | (0.7 ± 0.2) × 10?2 | 17.1, 16.2 |
Y30F/Y55F/D38N | (2.5 ± 0.7) × 10?1 | Not Detected |
Y30F/Y55F/Y115F/D38N | (3.4 ± 0.7) × 10?1 | Not Detected |
aThe
bValues are mean ± standard deviation from three independent experiments.
cOnly the 1H NMR resonance ranging from 16 to 20 ppm, which is regarded as the most unambiguous evidence for the presence of LBHBs in proteins, were investigated to identify the presence of LBHB in the mutant KSIs.
. Affinities of D38N and Y30F/Y55F/Y115F/D38N KSI for the steroid inhibitorsa
Enzyme | Steroid | Highly deshielded 1H resonance (ppm)c | |
---|---|---|---|
D38N | equilenin | (3.1 ± 0.6) × 10?2 | 16.8 |
androstenolone | (3.0 ± 0.7) × 10?1 | 16.8 | |
estrone | (1.1 ± 0.4) × 10?1 | 18.0 | |
Y30F/Y55F/Y115F/D38N | equilenin | (3.4 ± 0.7) × 10?1 | Not Detected |
androstenolone | 3.2 ± 0.3 | Not Detected | |
estrone | 1.0 ± 0.2 | Not Detected |
aMeasurements were performed in 10 mM potassium phosphate buffer containing 10% dimethyl sulfoxide.
bValues are mean ± standard deviation from three independent experiments.
cOnly the 1H NMR resonances ranging from 16 to 20 ppm were investigated to identify the presence of LBHB in KSI.
. Kinetic parameters of the wild type and its mutant KSIsa
Enzyme | Relative | |||
---|---|---|---|---|
WT b | (21.2 ± 0.8) × 103 | 49.9 ± 1.3 | 4.3 × 108 | 1 |
Y14F c | 13.3 ± 0.6 | 17.1 ± 3.1 | 7.8 × 105 | 10?3.2 |
Y30F d | (17.8 ± 0.1) × 103 | 55.2 ± 2.0 | 3.3 × 108 | 0.84 |
Y55F d | (35.1 ± 0.6) × 102 | 23.0 ± 1.0 | 1.5 × 108 | 0.17 |
Y115F | (14.5 ± 0.4) × 103 | 41.7 ± 2.0 | 3.5 × 108 | 0.68 |
Y30F/Y55F d | (10.7 ± 0.4) × 103 | 50.2 ± 5.5 | 2.1 × 108 | 0.50 |
Y30F/Y55F/Y115F | (12.2 ± 0.2) × 103 | 77.3 ± 5.6 | 1.6 × 108 | 0.57 |
aThe assays were performed in a buffer containing 34 mM potassium phosphate, pH 7.0, 2.5 mM EDTA and 3.3 % methanol.
bData from Kim et al. (1999).
cData from Kim and Choi (1995).
dData from Kim et al. (2000).
Mol. Cells 2015; 38(5): 409-415
Published online May 31, 2015 https://doi.org/10.14348/molcells.2015.2266
Copyright © The Korean Society for Molecular and Cellular Biology.
Do Soo Jang1,2,7, Gildon Choi3,7, Hyung Jin Cha1,4,7, Sejeong Shin5, Bee Hak Hong1,2, Hyeong Ju Lee6, Hee Cheon Lee6, and Kwan Yong Choi1,*
1Department of Life Sciences, Pohang University of Science and Technology, Pohang 790-784, Korea, 2Research Institute, Genexine Co., Seongnam 463-400, Korea, 3Korea Research Institute of Chemical Technology, Daejeon 305-343, Korea, 4Pohang Accelerator Laboratory, Pohang University of Science and Technology, Pohang 790-784, Korea, 5Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA, 6Department of Chemistry, Pohang University of Science and Technology, Pohang 790-784, Korea, 7These authors contributed equally to this work.
Correspondence to:*Correspondence: kchoi@postech.ac.kr
Low-barrier hydrogen bonds (LBHBs) have been proposed to have important influences on the enormous reaction rate increases achieved by many enzymes. Δ5-3-ketosteroid isomerase (KSI) catalyzes the allylic isomerization of Δ5-3-ketosteroid to its conjugated Δ4-isomers at a rate that approaches the diffusion limit. Tyr14, a catalytic residue of KSI, has been hypothesized to form an LBHB with the oxyanion of a dienolate steroid intermediate generated during the catalysis. The unusual chemical shift of a proton at 16.8 ppm in the nuclear magnetic resonance spectrum has been attributed to an LBHB between Tyr14 Oη and C3-O of equilenin, an intermediate analogue, in the active site of D38N KSI. This shift in the spectrum was not observed in Y30F/Y55F/D38N and Y30F/Y55F/Y115F/D38N mutant KSIs when each mutant was complexed with equilenin, suggesting that Tyr14 could not form LBHB with the intermediate analogue in these mutant KSIs. The crystal structure of Y30F/Y55F/Y115F/D38N-equilenin complex revealed that the distance between Tyr14 Oη and C3-O of the bound steroid was within a direct hydrogen bond. The conversion of LBHB to an ordinary hydrogen bond in the mutant KSI reduced the binding affinity for the steroid inhibitors by a factor of 8.1?11. In addition, the absence of LBHB reduced the catalytic activity by only a factor of 1.7?2. These results suggest that the amount of stabilization energy of the reaction intermediate provided by LBHB is small compared with that provided by an ordinary hydrogen bond in KSI.
Keywords: enzyme catalysis, ketosteroid isomerase, low-barrier hydrogen bond, Tyr14
One of the fundamental questions in enzyme catalysis is how an enzyme can stabilize a reaction intermediate and transition state during enzymatic reaction to accelerate the enzyme-catalyzed reaction rate over the non-enzymatic one. The low-barrier hydrogen bond (LBHB) has been invoked to explain a large amount of the energy that is required to stabilize the intermediate in many enzyme reactions (Gerlt and Gassman, 1993). An LBHB has been hypothesized to occur when the distance between the two heteroatoms is less than the sum of their van der Waals radii and the p
Δ5-3-ketosteroid isomerase (KSI) catalyzes the allylic rearrangement of the 5,6 double bond of Δ5-3-ketosteroids to the 4,5 position, and accelerates the reaction by a factor of 1011 compared to the nonenzymatic reaction by an intramolecular proton transfer (Fig. 1) (Pollack, 2004). Two bacterial KSIs, one from
In this study, we measured the energetic difference between LBHB and the ordinary hydrogen bond in the active site of
5-androstene-3,17-dione (5-AND), androstenolone, equilenin and estrone were purchased from Steraloids Inc. (USA). 15N-Labeled NH4Cl was purchased from Cambridge Isotope Laboratories Inc. (USA). A Superose 12 gel filtration column was purchased from Amersham Bioscience (USA). All chemicals for the buffer solution were purchased from Sigma (USA). All enzymes for DNA manipulation were purchased from Promega (USA). Oligonucleotides were obtained from Genotech Inc. (Korea).
Site-directed mutagenesis of Y115F, Y115F/D38N, Y30F/Y55F/Y115F, Y30F/Y55F/D38N and Y30F/Y55F/Y115F/D38N was conducted as described previously (Kim et al., 2000). All mutations were confirmed by sequencing the entire gene of the mutant KSI. Mutant KSIs were overexpressed in
NMR was performed as described previously (Jang et al., 2006). The NMR sample was adjusted to contain 15 mg/ml KSI in 40 mM potassium phosphate buffer at pH 7.0 containing 1 mM EDTA and 10% DMSO-d6 (dimethyl sulfoxide-d6) (v/v). NMR spectra were collected on a spectrometer (Bruker, Avance DRX500) equipped with a triple resonance, pulse field gradient probe with actively-shielded z-axis gradients, and a gradient amplifier unit. A jump-and-return pulse sequence (Plateau and Gueron, 1982) was used to suppress the water signal. The observed 1H chemical shifts were determined relative to that of sodium 2,2-dimethyl-2-silapentane-5-sulfonate as an internal standard. All experiments were conducted at 270 K with 1,000 scans acquired for each spectrum; the relaxation delay was 2 s. The spectral width of 20,000 Hz was used in 16,384 points. Line-broadening of 10 Hz was used when processing the data on a workstation (Silicon Graphics, IndyPC) using a software program XWIN-NMR v. 1.2.
The affinity of KSI for equilenin, androstenolone, or estrone was assessed by measuring the extent of quenching of intrinsic tryptophan fluorescence of KSI upon the binding of the respective steroid. The fluorescence intensities of KSI were measured with excitation at 295 nm and emission at 315 nm after adding successively various amounts of the steroid dissolved in DMSO to the solution of KSI. After correcting the data with appropriate dilution factors, dissociation constants were determined by fitting the data to the following equation:
Enzymatic reactions were initiated by adding KSI to 3 ml of a solution containing 34 mM potassium phosphate, pH 7.0, 2.5 mM EDTA, 3.3% methanol, and the respective amount of a steroid substrate, 5-AND. The final concentration of methanol in the reaction mixture was 3.3% by volume. All the assays were performed at 298 K. Kinetic parameters such as
Crystallization of Y30F/Y55F/Y115F/D38N KSI complexed with equilenin was conducted using a hanging drop vapor diffusion method as described previously (Cha et al., 2014; Cho et al., 1999). After 20 mg/ml of the mutant KSI was prepared in a buffer containing 40 mM potassium phosphate, pH 7.0, 1 mM EDTA, and 20 mM β-mercaptoethanol, the 70 μl of this solution was mixed with 2 μl of 10 mM equilenin in dimethyl sulfoxide. The optimized crystallization for the mutant KSI was 0.1 M sodium acetate, pH 4.5, 0.6 M ammonium acetate, and 30% PEG 4000. All diffraction data were collected on beamline 5C at Po-hang Accelerator Laboratory (PAL), Korea. The diffraction images were integrated and scaled using the HKL-2000 software package (Otwinowski and Minor, 1997). The structure of Y30F/Y55F/Y115F/D38N complexed with equilenin was determined by the molecular replacement method using as a search model the coordinates of wild-type KSI that had been determined previously (Kim et al., 1997a). Model building was performed using Coot (Emsley et al., 2010) and refinement was performed using Phenix.refine (Afonine et al., 2012). The atomic coordinate of Y30F/Y55F/Y115F/D38N complexed with equilenin was deposited at the Protein Data Bank (PDB code 5AI1).
The Y30F/Y55F/Y115F/D38N mutant KSI that contains no tyrosine residue other than Tyr14 was prepared to investigate the role of Tyr14 in the formation of LBHB without any interference from the other three tyrosines (Tyr30, Tyr55, Tyr115) in
The
The
The binding mode of equilenin in the active site of Y30F/Y55F/Y115F/D38N was investigated using X-ray crystallography. The crystals of Y30F/Y55F/Y115F/D38N-equilenin complex were found to belong to the C2221 space group with unit cell dimensions of a = 35.2 ?, b = 95.8 ? and c = 73.5 ?. The final structure of Y30F/Y55F/Y115F/D38N-equilenin complex was determined at 2.1-? resolution. The crystallographic statistics for the final structure are shown in Supplementary Table 1. The crystal structure of the mutant revealed that the benzyl side chains of the substituted phenylalanines were located at the positions similar to those of the corresponding tyrosine residues in D38N but without the hydroxyl groups (Fig. 4). The hydrogen bond geometry between equilenin and catalytic residues in Y30F/Y55F/Y115F/D38N was very similar to that in D38N. The bound steroid was located in the active site of the mutant with the steroid A-ring approaching Tyr14 and Asp99 (Fig. 4; Supplementary Fig. 1). Three catalytic residues, Tyr14, Asp38 and Asp99, which are critical for the catalytic activity of KSI, were found to be located at positions similar to those in D38N. Tyr14 Oη was involved in a hydrogen bond with C3-O of equilenin with a distance of 2.80 ? in the active site of Y30F/Y55F/Y115F/D38N complexed with the steroid.
Using KSI as a model system, we investigated the nature and origin of stabilization of the reaction intermediate or the transition-state to explain the enormous rate enhancement of the enzyme-catalyzed reaction over the non-enzymatic reaction. Especially, we investigated the proposition that LBHB can provide an additional energetic contribution to enzyme catalysis compared with the ordinary hydrogen bond. In
Tyr14 Oη forms a hydrogen bond with Tyr55 Oη that is in turn hydrogen-bonded to Tyr30 Oη in the active site of
The 1H NMR spectrum and crystal structure of the Y30F/Y55F/Y115F/D38N KSI complexed with equilenin revealed that LBHB between Tyr14 Oη and C3-O of the steroid in D38N was replaced by an ordinary hydrogen bond. The affinities of the Y30F/Y55F/Y115F/D38N KSI for steroid inhibitors (androstenolone, estrone, equilenin), were lower by factors of 9.1?11 than those of the D38N KSI; this change corresponds to a decrease of only 1.3?1.4
The proton transfer by KSI from the C4 proton of 5-AND with p
In conclusion, we have shown that the conversion of LBHB to an ordinary hydrogen bond resulted in only marginal decrease of the catalytic activity and the binding affinity for the intermediate analogue in
. Effects of the tyrosine-to-phenylalanine substitutions in
KSI | Highly deshielded1H resonance (ppm)c | |
---|---|---|
D38N | (3.1 ± 0.6) × 10?2 | 16.8 |
Y30F/D38N | (0.7 ± 0.1) × 10?2 | 17.6 |
Y55F/D38N | (0.8 ± 0.2) × 10?2 | 17.9 |
Y115F/D38N | (0.7 ± 0.2) × 10?2 | 17.1, 16.2 |
Y30F/Y55F/D38N | (2.5 ± 0.7) × 10?1 | Not Detected |
Y30F/Y55F/Y115F/D38N | (3.4 ± 0.7) × 10?1 | Not Detected |
aThe
bValues are mean ± standard deviation from three independent experiments.
cOnly the 1H NMR resonance ranging from 16 to 20 ppm, which is regarded as the most unambiguous evidence for the presence of LBHBs in proteins, were investigated to identify the presence of LBHB in the mutant KSIs.
. Affinities of D38N and Y30F/Y55F/Y115F/D38N KSI for the steroid inhibitorsa.
Enzyme | Steroid | Highly deshielded 1H resonance (ppm)c | |
---|---|---|---|
D38N | equilenin | (3.1 ± 0.6) × 10?2 | 16.8 |
androstenolone | (3.0 ± 0.7) × 10?1 | 16.8 | |
estrone | (1.1 ± 0.4) × 10?1 | 18.0 | |
Y30F/Y55F/Y115F/D38N | equilenin | (3.4 ± 0.7) × 10?1 | Not Detected |
androstenolone | 3.2 ± 0.3 | Not Detected | |
estrone | 1.0 ± 0.2 | Not Detected |
aMeasurements were performed in 10 mM potassium phosphate buffer containing 10% dimethyl sulfoxide.
bValues are mean ± standard deviation from three independent experiments.
cOnly the 1H NMR resonances ranging from 16 to 20 ppm were investigated to identify the presence of LBHB in KSI.
. Kinetic parameters of the wild type and its mutant KSIsa.
Enzyme | Relative | |||
---|---|---|---|---|
WT b | (21.2 ± 0.8) × 103 | 49.9 ± 1.3 | 4.3 × 108 | 1 |
Y14F c | 13.3 ± 0.6 | 17.1 ± 3.1 | 7.8 × 105 | 10?3.2 |
Y30F d | (17.8 ± 0.1) × 103 | 55.2 ± 2.0 | 3.3 × 108 | 0.84 |
Y55F d | (35.1 ± 0.6) × 102 | 23.0 ± 1.0 | 1.5 × 108 | 0.17 |
Y115F | (14.5 ± 0.4) × 103 | 41.7 ± 2.0 | 3.5 × 108 | 0.68 |
Y30F/Y55F d | (10.7 ± 0.4) × 103 | 50.2 ± 5.5 | 2.1 × 108 | 0.50 |
Y30F/Y55F/Y115F | (12.2 ± 0.2) × 103 | 77.3 ± 5.6 | 1.6 × 108 | 0.57 |
aThe assays were performed in a buffer containing 34 mM potassium phosphate, pH 7.0, 2.5 mM EDTA and 3.3 % methanol.
bData from Kim et al. (1999).
cData from Kim and Choi (1995).
dData from Kim et al. (2000).
Hyung Jin Cha, Do Soo Jang, Yeon-Gil Kim, Bee Hak Hong, Jae-Sung Woo, Kyong-Tai Kim, and Kwan Yong Choi
Mol. Cells 2013; 36(1): 39-46 https://doi.org/10.1007/s10059-013-0013-1